138 related articles for article (PubMed ID: 23522893)
21. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
22. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
[TBL] [Abstract][Full Text] [Related]
23. What is your guess? Lactescent plasma in acute leukemia.
Leung-Pineda V; Dietzen DJ
Clin Chem; 2011 Aug; 57(8):1213-4. PubMed ID: 21724972
[No Abstract] [Full Text] [Related]
24. Cerebral thrombotic complications in adolescent leukemia/lymphoma patients treated with L-asparaginase-containing chemotherapy.
Imamura T; Morimoto A; Kato R; Izumi M; Murakami A; Matuo S; Kiyosawa N; Kano G; Yoshioka H; Sugimoto T; Imashuku S
Leuk Lymphoma; 2005 May; 46(5):729-35. PubMed ID: 16019511
[TBL] [Abstract][Full Text] [Related]
25. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
Tozuka M; Yamauchi K; Hidaka H; Nakabayashi T; Okumura N; Katsuyama T
Ann Clin Lab Sci; 1997; 27(5):351-7. PubMed ID: 9303174
[TBL] [Abstract][Full Text] [Related]
26. Two cases of pegylated asparaginase-associated severe and persistent hyperbilirubinemia.
Kim S
Am J Hematol; 2009 Oct; 84(10):696. PubMed ID: 19731309
[No Abstract] [Full Text] [Related]
27. Importance of Acute Lymphoblastic Leukemia-type Therapy for Bilineal Acute Leukemia.
Nakagawa S; Okamoto Y; Kodama Y; Nishikawa T; Tanabe T; Kawano Y
J Pediatr Hematol Oncol; 2019 Aug; 41(6):504-506. PubMed ID: 30198961
[TBL] [Abstract][Full Text] [Related]
28. Hemophagocytic lymphohistiocytosis onset during induction therapy for precursor B-cell acute lymphoblastic leukemia.
Breakey VR; Abdelhaleem M; Weitzman S; Abla O
J Pediatr Hematol Oncol; 2008 Dec; 30(12):956-8. PubMed ID: 19131791
[TBL] [Abstract][Full Text] [Related]
29. Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia.
Silverman LB; Supko JG; Stevenson KE; Woodward C; Vrooman LM; Neuberg DS; Asselin BL; Athale UH; Clavell L; Cole PD; Kelly KM; Laverdière C; Michon B; Schorin M; Schwartz CL; O'Brien JE; Cohen HJ; Sallan SE
Blood; 2010 Feb; 115(7):1351-3. PubMed ID: 20007809
[TBL] [Abstract][Full Text] [Related]
30. Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
Messinger YH; Gaynon PS; Sposto R; van der Giessen J; Eckroth E; Malvar J; Bostrom BC;
Blood; 2012 Jul; 120(2):285-90. PubMed ID: 22653976
[TBL] [Abstract][Full Text] [Related]
31. Lipid Apheresis to Manage Severe Hypertriglyceridemia during Induction Therapy in a Child with Acute Lymphoblastic Leukemia.
Mayerhofer C; Speckmann C; Kapp F; Teufel-Schäfer U; Kluwe W; Schneider J; Flotho C
Pediatr Hematol Oncol; 2020 Sep; 37(6):530-538. PubMed ID: 32374222
[TBL] [Abstract][Full Text] [Related]
32. COVID-19 reinfection in two children with cancer.
Yadav SP; Wadhwa T; Thakkar D; Kapoor R; Rastogi N; Sarma S
Pediatr Hematol Oncol; 2021 May; 38(4):403-405. PubMed ID: 33625290
[No Abstract] [Full Text] [Related]
33. Low-dose nivolumab-induced responses in acute lymphoblastic leukaemia relapse after allogeneic haematopoietic stem cell transplantation.
Chan TSY; Sim JPY; Kwong YL
Ann Hematol; 2017 Sep; 96(9):1569-1572. PubMed ID: 28573313
[No Abstract] [Full Text] [Related]
34. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
[TBL] [Abstract][Full Text] [Related]
35. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P
Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and outcome of pediatric acute lymphoblastic leukemia with low peripheral blood blast cell count at diagnosis.
Dai Q; Zhang G; Yang H; Wang Y; Ye L; Peng L; Shi R; Guo S; He J; Jiang Y
Medicine (Baltimore); 2021 Jan; 100(4):e24518. PubMed ID: 33530278
[TBL] [Abstract][Full Text] [Related]
37. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
Gururangan S; Horner M; Rodman JH; Marina NM
Med Pediatr Oncol; 1994; 22(6):414-6. PubMed ID: 8152404
[TBL] [Abstract][Full Text] [Related]
39. Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia.
Theodoulou A; Berryman J; Nathwani A; Scully M
Transfus Apher Sci; 2012 Apr; 46(2):159-62. PubMed ID: 22227402
[TBL] [Abstract][Full Text] [Related]
40. Double minute chromosomes and c-MYC amplification in a child with secondary myelodysplastic syndrome after treatment for acute lymphoblastic leukemia.
Mathew S; Lorsbach RB; Shearer P; Sandlund JT; Raimondi SC
Leukemia; 2000 Jul; 14(7):1314-5. PubMed ID: 10914558
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
